Healthcare provider profile · identity verified

Jonathan Andrews, FNP

Nurse Practitioner · SALISBURY, MD · NPI 1073006862

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	548	133
Eliquis	Apixaban	382	62
Amlodipine Besylate	Amlodipine Besylate	285	78
Gabapentin	Gabapentin	255	63
Jardiance	Empagliflozin	245	32
Sertraline Hcl	Sertraline Hcl	245	52
Levothyroxine Sodium	Levothyroxine Sodium	243	51
Oxycodone Hcl	Oxycodone Hcl	226	36
Furosemide	Furosemide	196	72
Tamsulosin Hcl	Tamsulosin Hcl	195	51
Losartan Potassium	Losartan Potassium	185	43
Metoprolol Succinate	Metoprolol Succinate	168	49
Buspirone Hcl	Buspirone Hcl	161	34
Trazodone Hcl	Trazodone Hcl	160	38
Metoprolol Tartrate	Metoprolol Tartrate	146	35
Carvedilol	Carvedilol	129	40
Pantoprazole Sodium	Pantoprazole Sodium	123	49
Clopidogrel	Clopidogrel Bisulfate	119	31
Potassium Chloride	Potassium Chloride	119	36
Metformin Hcl Er	Metformin Hcl	112	19
Lorazepam	Lorazepam	108	39
Farxiga	Dapagliflozin Propanediol	107	suppressed
Tramadol Hcl	Tramadol Hcl	103	39
Famotidine	Famotidine	100	26
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	97	13
Fluoxetine Hcl	Fluoxetine Hcl	96	15
Escitalopram Oxalate	Escitalopram Oxalate	94	23
Levetiracetam	Levetiracetam	90	15
Divalproex Sodium	Divalproex Sodium	86	17
Mirtazapine	Mirtazapine	85	26
Quetiapine Fumarate	Quetiapine Fumarate	82	21
Clonazepam	Clonazepam	81	14
Myrbetriq	Mirabegron	80	suppressed
Xarelto	Rivaroxaban	78	16
Omeprazole	Omeprazole	76	28
Duloxetine Hcl	Duloxetine Hcl	74	17
Lisinopril	Lisinopril	73	22
Entresto	Sacubitril/Valsartan	69	suppressed
Metformin Hcl	Metformin Hcl	69	24
Oxybutynin Chloride Er	Oxybutynin Chloride	68	13
Humalog Kwikpen U-100	Insulin Lispro	60	12
Memantine Hcl	Memantine Hcl	60	15
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	59	16
Aripiprazole	Aripiprazole	58	12
Pregabalin	Pregabalin	58	12
Baclofen	Baclofen	57	suppressed
Montelukast Sodium	Montelukast Sodium	57	17
Olanzapine	Olanzapine	55	12
Triamcinolone Acetonide	Triamcinolone Acetonide	55	19
Risperidone	Risperidone	51	suppressed
Spironolactone	Spironolactone	50	16
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	49	24
Rosuvastatin Calcium	Rosuvastatin Calcium	48	18
Allopurinol	Allopurinol	46	16
Ondansetron Hcl	Ondansetron Hcl	46	35
Oxcarbazepine	Oxcarbazepine	45	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	45	12
Tresiba Flextouch U-100	Insulin Degludec	45	suppressed
Glipizide	Glipizide	44	suppressed
Donepezil Hcl	Donepezil Hcl	43	15
Ozempic	Semaglutide	43	suppressed
Finasteride	Finasteride	42	11
Amiodarone Hcl	Amiodarone Hcl	40	18
Torsemide	Torsemide	39	12
Warfarin Sodium	Warfarin Sodium	39	suppressed
Bupropion Xl	Bupropion Hcl	38	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	38	suppressed
Lokelma	Sodium Zirconium Cyclosilicate	38	suppressed
Fiasp Flextouch	Insulin Aspart (Niacinamide)	37	suppressed
Simvastatin	Simvastatin	37	suppressed
Ropinirole Hcl	Ropinirole Hcl	34	suppressed
Janumet Xr	Sitagliptin Phos/Metformin Hcl	33	suppressed
Latanoprost	Latanoprost	33	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	33	suppressed
Tizanidine Hcl	Tizanidine Hcl	33	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	32	suppressed
Nebivolol Hcl	Nebivolol Hcl	32	suppressed
Rivastigmine	Rivastigmine Tartrate	31	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	29	22
Sucralfate	Sucralfate	29	12
Divalproex Sodium Er	Divalproex Sodium	28	suppressed
Valsartan	Valsartan	28	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	27	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	27	suppressed
Pravastatin Sodium	Pravastatin Sodium	27	suppressed
Amoxicillin	Amoxicillin	25	suppressed
Citalopram Hbr	Citalopram Hydrobromide	25	suppressed
Enulose	Lactulose	25	suppressed
Ketoconazole	Ketoconazole	25	13
Permethrin	Permethrin	25	19
Prednisone	Prednisone	25	14
Tresiba Flextouch U-200	Insulin Degludec	25	suppressed
Azelastine Hcl	Azelastine Hcl	24	suppressed
Benztropine Mesylate	Benztropine Mesylate	24	suppressed
Clonidine Hcl	Clonidine Hcl	24	suppressed
Albuterol Sulfate	Albuterol Sulfate	23	suppressed
Alprazolam	Alprazolam	23	suppressed
Brilinta	Ticagrelor	23	suppressed
Meloxicam	Meloxicam	23	suppressed
Januvia	Sitagliptin Phosphate	22	suppressed
Lamotrigine	Lamotrigine	22	suppressed
Ranolazine Er	Ranolazine	22	suppressed
Clozapine	Clozapine	21	suppressed
Hydralazine Hcl	Hydralazine Hcl	21	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	21	suppressed
Primidone	Primidone	21	suppressed
Cephalexin	Cephalexin	20	17
Nyamyc	Nystatin	20	15
Xtampza Er	Oxycodone Myristate	20	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	19	suppressed
Paroxetine Hcl	Paroxetine Hcl	19	suppressed
Breo Ellipta	Fluticasone/Vilanterol	18	suppressed
Morphine Sulfate	Morphine Sulfate	18	12
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	17	13
Carbidopa-Levodopa	Carbidopa/Levodopa	17	suppressed
Bumetanide	Bumetanide	16	suppressed
Fycompa	Perampanel	16	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	15	suppressed
Fluticasone Propionate	Fluticasone Propionate	15	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	15	suppressed
Roflumilast	Roflumilast	15	suppressed
Sevelamer Carbonate	Sevelamer Carbonate	15	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	15	13
Brimonidine Tartrate	Brimonidine Tartrate	14	suppressed
Midodrine Hcl	Midodrine Hcl	14	suppressed
Morphine Sulfate Er	Morphine Sulfate	14	suppressed
Novolog Flexpen	Insulin Aspart	14	suppressed
Spiriva Handihaler	Tiotropium Bromide	14	suppressed
Trulicity	Dulaglutide	14	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	13	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	13	12
Janumet	Sitagliptin Phos/Metformin Hcl	13	suppressed
Loperamide	Loperamide Hcl	13	suppressed
Timolol Maleate	Timolol Maleate	13	suppressed
Trintellix	Vortioxetine Hydrobromide	13	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	13	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	12	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	12	suppressed
Combigan	Brimonidine Tartrate/Timolol	12	suppressed
Ezetimibe	Ezetimibe	12	suppressed
Fenofibrate	Fenofibrate,micronized	12	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	12	suppressed
Labetalol Hcl	Labetalol Hcl	12	suppressed
Lacosamide	Lacosamide	12	suppressed
Namzaric	Memantine Hcl/Donepezil Hcl	12	suppressed
Nifedipine Er	Nifedipine	12	suppressed
Tradjenta	Linagliptin	12	suppressed
Amantadine	Amantadine Hcl	11	suppressed
Desvenlafaxine Er	Desvenlafaxine	11	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	11	suppressed
Fiasp	Insulin Aspart (Niacinamide)	11	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error